Nanoparticle-Based Targeted Drug Delivery Methods for Heart-Specific Distribution in Cardiovascular Therapy

Area of Science:

• Cardiovascular Medicine
• Nanotechnology
• Pharmacology

Background:

• Cardiovascular diseases are a leading global cause of death, often requiring invasive surgeries.
• Current treatments for cardiovascular diseases focus on peripheral tissues, with limited direct cardiac drug delivery.
• Significant unmet medical needs exist for effective, non-invasive cardiovascular therapies.

Purpose of the Study:

• To review emerging strategies for non-invasive cardiac drug delivery.
• To explore the potential of nanoparticle-based systems for targeted myocardial delivery.
• To address challenges in delivering therapeutics for conditions like congestive heart failure and myocardial infarction.

Main Methods:

• Perspective review of current literature and emerging strategies.
• Focus on nanoparticle-based delivery systems.
• Discussion of receptor-mediated endocytosis and transcytosis mechanisms for cardiac targeting.

Main Results:

• Non-invasive strategies, particularly nanoparticle-based systems, show promise for cardiac drug delivery.
• Targeted delivery to the myocardium remains a significant challenge.
• Existing nanoparticle strategies for brain and cancer targeting may be adaptable for cardiac applications.

Conclusions:

• Nanoparticle-based drug delivery offers a promising avenue for non-invasive cardiac therapeutics.
• Further research is needed to optimize these systems for effective myocardial targeting.
• Advancing non-invasive cardiac drug delivery is critical for managing cardiovascular diseases.